Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

ClinicalTrials.gov ID: NCT07497880

Public ClinicalTrials.gov record NCT07497880. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 1:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to determine the efficacy of oral KAI-7535 once daily compared with placebo on percent change in body weight in participants living with obesity or overweight, with at least 1 weight-related comorbidity, without diabetes mellitus. Safety and tolerability and other weight-related outcomes will also be evaluated.

Study identification

NCT ID
NCT07497880
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Kailera
Industry
Enrollment
306 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 6, 2026 (Actual)
Primary completion
Jul 7, 2027 (Estimated)
Completion
Jul 7, 2027 (Estimated)
Last update posted
Sep 9, 2026

2026 – 2027

United States locations

U.S. sites
31
U.S. states
14
U.S. cities
28
Facility City State ZIP Site status
Kailera Clinical Site Chandler Arizona 85225 —
Kailera Clinical Site Phoenix Arizona 85044 —
Kailera Clinical Site Irvine California 92614 —
Kailera Clinical Site Lincoln California 95648 —
Kailera Clinical Site Northridge California 91325 —
Kailera Clinical Site Hamden Connecticut 06517 —
Kailera Clinical Site Jacksonville Florida 32256 —
Kailera Clinical Site Jupiter Florida 33458 —
Kailera Clinical Site Palm Springs Florida 33461 —
Kailera Clinical Site Pembroke Pines Florida 33024 —
Kailera Clinical Site Decatur Georgia 30030 —
Kailera Clinical Site Chicago Illinois 60640 —
Kailera Clinical Site Skokie Illinois 60077 —
Kailera Clinical Site South Bend Indiana 46617 —
Kailera Clinical Site Kenner Louisiana 70065 —
Kailera Clinical Site Garden City Michigan 48135 —
Kailera Clinical Site Jefferson City Missouri 65109 —
Kailera Clinical Site Kansas City Missouri 64151 —
Kailera Clinical Site Spartanburg South Carolina 29303 —
Kailera Clinical Site Knoxville Tennessee 37909 —
Kailera Clinical Site Austin Texas 78705 —
Kailera Clinical Site Austin Texas 78757 —
Kailera Clinical Site Brownsville Texas 78520 —
Kailera Clinical Site Farmers Branch Texas 75234 —
Kailera Clinical Site Fort Worth Texas 76135 —
Kailera Clinical Site Mesquite Texas 75149 —
Kailera Clinical Site San Antonio Texas 78222 —
Kailera Clinical Site San Antonio Texas 78229 —
Kailera Clinical Site San Antonio Texas 78240 —
Kailera Clinical Site Sugar Land Texas 77479 —
Kailera Clinical Site Sandy City Utah 84093 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07497880, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2026 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07497880 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →